周五,Wolfe Research对诊断公司Veracyte, Inc (NASDAQ:VCYT)的股票进行了首次评级,给予"优于大市"评级,目标价为$50.00。该研究机构强调了Veracyte自2021年以来显著的收入增长和毛利率扩张。据该研究机构称,Veracyte的收入已翻倍,毛利率提高了约500个基点。 该公司有望在本年度实现9000万至1亿美元的调整后EBITDA。Wolfe Rese ...
Tobin Marcus, Wolfe Research policy and politics head, joins CNBC's 'Squawk Box' to discuss what Trump's pick for HHS ...
Fintel reports that on November 14, 2024, Wolfe Research initiated coverage of Maravai LifeSciences Holdings (NasdaqGS:MRVI) ...
Wolfe Research analyst Alexandria Hammond initiated coverage of Johnson & Johnson with an Outperform rating and $190 price target ...
周四,Wolfe Research开始对Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI)的股票进行覆盖,给予同业表现评级。该公司强调了Maravai LifeSciences的几个积极方面,包括其同类最佳的产品、提高客户效率的作用、高比例的耗材收入,以及具有显著改善潜力的可观利润率。 分析师指出,该公司面临的主要挑战在于其大部分收入来自mRNA生物制 ...
Wolfe Research has upgraded Warner Bros. Discovery (WBD, Financials) to "peer perform" from "underperform," citing a balanced risk/reward outlook despite Warner Bros. Discoverys $40 billion in ...
Wolfe Research upgrades Warner Bros. Discovery to peer perform, citing potential for stable EBITDA and debt reduction through ...
Wolfe Research has upgraded Warner Bros. Discovery (WBD, Financials) to "peer perform" from "underperform," citing a balanced risk/reward outlook despite Warner Bros. Discoverys $40 billion in gross ...
Wolfe Research downgraded Alnylam (ALNY) to Underperform from Peer Perform with a $205 price target The firm cites expectations that the company will expand its approved Amvuttra into the much ...
Investing.com - Wolfe Research has upgraded shares of Warner Bros. Discovery (NASDAQ:WBD) to Peer Perform from Underperform following its Q3 results last week, and assigned a fair value range of $ ...
It’s now up to the state Supreme Court to decide. Democrats are relying on precedent that they fought against to retain ...
On Monday, Wolfe Research adjusted its stance on shares of Danaher Corporation (NYSE:DHR), upgrading the stock from Peerperform to Outperform and setting a new price target of $285.00. The ...